Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1999;94:107-111
© 1999 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HSU, J. J.
Right arrow Articles by SPENCER, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HSU, J. J.
Right arrow Articles by SPENCER, K.

ORIGINAL RESEARCH

Urine Free Beta-hCG and Total Estriol for Down Syndrome Screening During the Second Trimester in an Asian Population

JENN J. HSU, MD, TE Y. HSU, MD, T’SANG T. HSIEH, MD, YUNG K. SOONG, MD, FON J. HSIEH, MD and KEVIN SPENCER, FRSC

From theTaiwan Down Syndrome Screening Group: the Department of Obstetrics and Gynecology, Taipei Chang Gung Memorial Hospital, Taipei; Lin-Kou Chang Gung Memorial Hospital, Tau-Young; Kashung Chang Gung Memorial Hospital, Kashung; and National Taiwan University Hospital, Taipei, Taiwan; and the Endocrine Unit, Department of Clinical Biochemistry, Harold Wood Hospital, Romford, Essex, United Kingdom.

Address reprint requests to: Jenn J. Hsu, MD, Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, 199, Tung-Hwa North Road, Taipei, Taiwan, E-mail: jjhsu{at}ms6.hinet.net

Objective: To evaluate second-trimester free ß-hCG and total estriol (E3) in the maternal urine as markers for Down syndrome screening in an Asian population.

Methods: Free ß-hCG and total E3 were measured in the urine samples of 28 Taiwanese Down syndrome pregnancies and 268 unaffected singleton pregnancies at 14–25 weeks. Results were normalized to urine creatinine concentrations and converted to multiples of the median (MoM) levels. Gestational ages were estimated by ultrasound measurements.

Results: Median values of free ß-hCG, total E3, free ß-hCG to total E3 ratio, and the free ß-hCG to total E3 MoM ratio in Down syndrome pregnancies were 4.75 MoM, 0.66 MoM, 8.99 MoM, and 9.51, respectively. At a 5% false-positive rate, the observed detection rates were 36% (ten of 28) with total E3, 71% (20 of 28) with free ß-hCG, 68% (19 of 28) with free ß-hCG/total E3, and 71% (20 of 28) with free ß-hCG/total E3 MoM. When combined with maternal age, the expected detection rates were 65% with total E3, 71% with free ß-hCG, 76% with free ß-hCG/total E3, 80% with free ß-hCG/total E3 MoM, and 89% when combining free ß-hCG, total E3, and maternal age.

Conclusion: Urine free ß-hCG and total E3 are useful markers for Down syndrome screening during the second trimester in Taiwanese women.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Obstetricians and Gynecologists.